APMD
Apnimed, Inc. - Common Stock (APMD)
$25
About Apnimed, Inc. - Common Stock (APMD)
Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.
Details
Daily high
$17.61
Daily low
$16.54
Price at open
$17.61
52 Week High
$35.29
52 Week Low
$13.88
Market cap
726.5M
Dividend yield
-
Volume
197,675
Avg. volume
399,318
P/E ratio
--
Apnimed, Inc. - Common Stock News
Details
Daily high
$17.61
Daily low
$16.54
Price at open
$17.61
52 Week High
$35.29
52 Week Low
$13.88
Market cap
726.5M
Dividend yield
-
Volume
197,675
Avg. volume
399,318
P/E ratio
--